Radich, J. P., Kopecky, K. J., Appelbaum, F. R., Kamel-Reid, S., Stock, W., Malnassy, G., . . . Druker, B. J. (2012). A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia. American Society of Hematology.
استشهاد بنمط شيكاغوRadich, Jerald P., et al. A Randomized Trial of Dasatinib 100 Mg Versus Imatinib 400 Mg in Newly Diagnosed Chronic-phase Chronic Myeloid Leukemia. American Society of Hematology, 2012.
MLA استشهادRadich, Jerald P., et al. A Randomized Trial of Dasatinib 100 Mg Versus Imatinib 400 Mg in Newly Diagnosed Chronic-phase Chronic Myeloid Leukemia. American Society of Hematology, 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.